Economic burden of stomach cancer in China during 1996-2015: a systematic review
10.3760/cma.j.issn.0253-9624.2017.08.018
- VernacularTitle: 中国1996—2015年胃癌经济负担研究的系统评价
- Author:
Fang YAO
1
;
Chunlei SHI
2
;
Chengcheng LIU
3
;
Le WANG
;
Shuming SONG
;
Jiansong REN
;
Chunguang GUO
;
Peian LOU
;
Min DAI
;
Lin ZHU
;
Jufang SHI
Author Information
1. Cancer Research Institute, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi 830011, China
2. Department of Control and Prevention of Chronic Non-communicable Diseases, Xuzhou Center for Disease Control and Prevention, Xuzhou 221006, China
3. Program Office for Cancer Screening in Urban China, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China
- Publication Type:Review
- Keywords:
Stomach neoplasms;
Cost of illness;
Economic burden;
Expenditure
- From:
Chinese Journal of Preventive Medicine
2017;51(8):756-762
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To clarify the research status of economic burden of stomach cancer in China from 1996 to 2015.
Methods:Based on three electronic literature databases (China Knowledge Resource Integrated Database, Wanfang Database and PubMed), a total of 2 873, 1 244 and 84 articles published during 1996 to 2015 were found, respectively, using keywords of"cancer","neoplasms","malignant tumor","tumor","economic burden","health expenditure","cost","cost of illness", and"China". According to the inclusion and exclusion criteria, 30 literatures were included in the final analysis. Then the basic information and study subjects, indicators and main results of economic burden were abstracted and analyzed. All the expenditure data were discounted to the values in 2013 by using China's percapita consumer price index.
Results:Totally, 30 articles were included, covering 14 provinces and of which 16 were published during 2011-2015. One article was based on population-level and the remaining studies were all based on individual-level. The number of individual-level articles that reported direct medical, non-medical and indirectly economic burden was 29, 1 and 2, respectively. The main indicators of direct medical expenditure were expenditure per patient (22), per clinical visit (9) and per diem (11), respectively. The median expenditure per patient was 7 387-28 743 RMB (CNY), with average annual growth rate (AAGR) of 1.7% (1996-2013). The median expenditure per clinical visit was 18 504-41 871 RMB (2003-2013), with AAGR of 5.5%. The median expenditure per diem was 313-1 445 RMB (1996-2012), with AAGR of 3.7%. Difference was found among provinces.
Conclusions:The evidence for economic burden of stomach cancer was still limited over the past two decades and mainly focused on individual and regional levels. An increase and differences in provinces were observed in direct medical expenditure. Evaluation on direct non-medical and indirect medical expenditure needs to be addressed.
